Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-05-03
2005-05-03
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252120, C514S331000, C514S428000, C514S569000, C514S633000, C544S162000, C544S401000, C546S231000, C548S569000, C564S229000
Reexamination Certificate
active
06887872
ABSTRACT:
The invention refers to novel propenecarboxylic acid amidoxime derivatives furthermore N-oxides and/or geometrical isomers and/or optical isomers and/or pharmaceutically suitable acid addition salts and/or quaternary derivatives thereof. The novel compounds are suitable for the treatment of a state connected with oxygen deficit and/or energy deficit, or a disease based on PARP inhibition, especially an autoimmune or neurodegenerative disease, and/or a viral disease, and/or a disease caused by a toxic effect.
REFERENCES:
patent: 4308399 (1981-12-01), Takacs et al.
patent: 6500823 (2002-12-01), Literati Nagy et al.
patent: 90 08131 (1990-07-01), None
patent: 00 14054 (2000-03-01), None
Literati Nagy Peter
Sumegi Balazs
Takacs Kalman
Birch & Stewart Kolasch & Birch, LLP
N-Gene Research Laboratiories Inc.
Raymond Richard L.
Tucker Zachary C.
LandOfFree
Propenecarboxylic acid amidoxime derivatives, a process for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Propenecarboxylic acid amidoxime derivatives, a process for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Propenecarboxylic acid amidoxime derivatives, a process for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3456757